This statistic shows the total revenues for contract research company IQVIA from 2013 to 2024, in million U.S. dollars. According to the company's last report in 2024, total revenues stood at some 15.4 billion U.S. dollars. IQVIA - formerly known as Quintiles and IMS Health, Inc. - is a U.S. company from Durham, North Carolina, active in clinical research and health IT.

This statistic shows the total revenue streams of contract researcher IQVIA from 2016 to 2024. In 2024, Technology & Analytics Solutions generated around 6.2 billion U.S. dollars in revenue. IQVIA - formerly known as Quintiles and IMS Health, Inc. - is a U.S. company from Durham, North Carolina, active in clinical research and health IT.

Iqvia Holdings is a public company headquartered in North Carolina with an estimated 86,000 employees. In the US, the company has a notable market share in at least three industries: Market Research, Clinical Trial Support Services, Contract Research Organizations and Clinical Trial Support Services. Their largest market share is in the Contract Research Organizations industry, where they account for an estimated 24.0% of total industry revenue and are considered an All Star because they display stronger market share, profit and revenue growth compared to their peers.

The research revenue of IQVIA, one of the leading market research companies worldwide, increased steadily since 2013. In 2024, the company recorded a revenue of approximately 6.16 billion U.S. dollars from this department.

The market research revenue of IQVIA in the United States increased significantly between 2013 and 2021. In 2021, the U.S. research company generated revenue of almost 2.5 billion U.S. dollars in the United States, an increase of approximately 350 million U.S. dollars compared to the previous year.

IQVIA Holdings reported $3.96B in Sales Revenues for its fiscal quarter ending in December of 2024. Data for IQVIA Holdings | IQV - Sales Revenues including historical, tables and charts were last updated by Trading Economics this last March in 2025.

IQVIA Holdings reported $11M in Interest Income for its fiscal quarter ending in December of 2024. Data for IQVIA Holdings | IQV - Interest Income including historical, tables and charts were last updated by Trading Economics this last March in 2025.

This statistic shows the annual net income of contract researcher IQVIA Holding Inc. from 2013 to 2024. In 2024, the net income of IQVIA was 1.37 billion U.S. dollars. IQVIA - formerly known as Quintiles and IMS Health, Inc. - is a U.S. company from Durham, North Carolina, active in clinical research and health IT.

In 2020, Nielsen was the leading market research and data analytics company in the United States in terms of revenue. Nielsen generated nearly 3.7 billion U.S. dollars in revenue in the United States, while abroad it generated over 2.6 billion U.S. dollars. Second in the ranking was IQVIA, whose revenues reached 4.35 billion euros dollars worldwide.

The net income of Iqvia Holdings with headquarters in the United States amounted to 1.4 billion U.S. dollars in 2023. The reported fiscal year ends on December 31.Compared to the earliest depicted value from 2019 this is a total increase by approximately 1.1 billion U.S. dollars. The trend from 2019 to 2023 shows, furthermore, that this increase happened continuously.

According to Cognitive Market Research, The Global Tin Containers market size is USD 15.8 billion in 2023 and will enhance at a compound annual growth rate (CAGR) of 5.50% from 2023 to 2030.

The demand for tin containers is rising due to various strategies adopted by key players.
Demand for food & beverages remains higher in the tin containers market.
The edible oil container category held the highest tin containers market revenue share in 2023.
Asia Pacific will continue to lead, whereas the North American tin containers market will experience the most substantial growth until 2030.

Increasing Food and Beverage Industry to Provide Viable Market Output

The growth of the food and beverage industry acts as a pivotal driver for the tin containers market. As consumer preferences evolve and environmental sustainability gains prominence, the demand for tin containers rises. Their advantages, including recyclability, corrosion resistance, and durability, align with the industry's packaging needs. Additionally, innovations in design and the expanding global market further propel the use of tin containers, making them a preferred choice for packaging various food and beverage products.

For instance, in February 2022, India's Food Safety and Standards Authority paved the way for packaging drinking water in non-transparent packaging solutions like aluminum liquid cans. Ball Corporation accepted the move as it will allow the firm to address the issues on the sustainability front and donate to the Government's ambition to hold single-use plastics and provide the end customer with an eco-friendly option.

(Source: www.iqvia.com/newsroom/2021/04/iqvia-announces-connected-intelligence)

Various Strategies Adopted by Key Players to Propel Market Growth

Key players in the tin containers market implement diverse strategies for success. These include leveraging sustainable packaging practices to meet rising environmental concerns, continuous product innovation to enhance functionality and appeal, and strategic partnerships to expand market reach. Emphasizing compliance with health and safety regulations, optimizing manufacturing processes through technology, and tapping into the growing e-commerce trend are additional strategies contributing to their market presence and growth. These multifaceted approaches reflect the dynamic nature of the tin containers market.

For instance, in August 2019, Ball Corporation inked an agreement with Envases del Plata SA to sell the tinplate steel aerosol packaging facilities in San Luis and Garin (Argentina).

(Source: investors.ball.com/news-and-presentations/news-releases/news-releases-details/2019/Ball-Agrees-to-Sell-its-Tinplate-Steel-Aerosol-Packaging-Facilities-in-Argentina/default.aspx)

Market Restraints of the Tin Containers

Competition from Alternative Materials to Restrict Market Growth

The tin containers market faces stiff competition from alternative materials like plastic and glass, which offer lighter weights and cost advantages. Plastic's versatility and glass's perceived premium quality challenge tin container market share. Moreover, the increasing emphasis on eco-friendly packaging amplifies the pressure on tin containers to demonstrate sustainability, as some alternatives are perceived as more environmentally friendly. To remain competitive, the tin containers industry must address these factors and continually innovate to meet evolving consumer and industry preferences for packaging materials.

Impact of COVID-19 on the Tin Containers Market

The COVID-19 pandemic initially disrupted the tin containers market due to supply chain challenges and reduced consumer spending. However, the demand for sustainable packaging solutions, like tin containers, has rebounded as awareness of hygiene and eco-friendly materials increased. The market's resilience stems from the versatility and durability of tin, meeting evolving consumer preferences. The ongoing recovery aligns with the broader sustainable packaging trend, positioning tin containers favorably in a post-pandemic landscape. Introduction of the Tin Containers Market

The expanding cosmetics and personal care industry is a significant driver for the tin containers market. Tin containers, valued for their durability and aesthetic appeal, find increasing application in packaging cosmetics such as creams and solid ...

According to Cognitive Market Research, the global life science software market size is USD 16.2 billion in 2023 and will enhance at a compound annual growth rate (CAGR) of 13.50% from 2023 to 2030.

The global life science software market will expand significantly by 13.50% CAGR between 2023 and 2030.
The demand for life science software is rising due to technological advancement.
Demand for marketing remains higher in the life science software market.
The on-premises category held the highest life science software market revenue share in 2023.
North America will continue to lead, whereas the European life science software market will experience the most substantial growth until 2030

Continuous Technological Advancements to Provide Viable Market Output

The life science software market is thriving due to continuous technological advancements. Innovations such as advanced analytics, artificial intelligence, and cloud computing are reshaping the industry. These technologies enhance research, drug development, and clinical trials, fostering efficiency and precision. The market's growth is fueled by a relentless pursuit of cutting-edge solutions, elevating the capabilities of life science professionals and organizations to drive breakthroughs in healthcare and biotechnology.

For instance, in April 2021, IQVIA established Connected Intelligence for customers to utilize analytical solutions to discover data-driven insights and help effective decision-making. IQVIA incorporated its expertise in healthcare analytics with creative technologies to provide Connected Intelligence solutions.

Increasing Usage of Analytics for Sales and Marketing Applications to Propel Market Growth

The life science software market is experiencing growth due to an escalating adoption of analytics in sales and marketing applications. Companies increasingly leverage data analytics to enhance decision-making processes, target specific customer segments, and optimize marketing strategies. This trend is driven by the desire for more efficient and targeted approaches, leading to improved customer engagement and increased sales. As analytics continue to play a pivotal role in business strategies, the life science software market is poised for sustained expansion. For instance, in February 2021, Nemours Children's Health System accepted analytical help from Oracle to adopt cloud business applications to be deployed in different business departments of the institution.

Market Dynamics For The Life Science Software Market

Data Privacy and Security Concerns to Restrict Market Growth

The life science software market faces significant restraints due to escalating data privacy and security concerns. As sensitive biological and patient data become increasingly digitalized, ensuring robust protection against unauthorized access and data breaches becomes paramount. Stringent regulatory requirements and the potential for reputational damage in case of security lapses contribute to a challenging landscape. Consequently, industry players must invest in advanced cybersecurity measures to alleviate concerns and foster trust in adopting life science software solutions.

Impact of COVID–19 on the Life Science Software Market

The life science software market witnessed significant growth accelerated by the COVID-19 pandemic. The increased demand for solutions supporting drug discovery, vaccine development, and data management in response to the global health crisis drove market expansion. As life sciences organizations prioritized digital transformation, the software market adapted to meet these evolving needs. This adoption surge addressed pandemic-related challenges and fostered long-term advancements in life science research and development. What is Life Science Software?

The life science software market is burgeoning due to rapid advancements in precision medicine. Innovations in data analytics, genomic sequencing, and clinical informatics are transforming healthcare. Precision medicine tailors treatments based on individual genetic, environmental, and lifestyle factors, optimizing outcomes. This paradigm shift drives demand for sophisticated software solutions, propelling the life science software market forward as a key enabler of personalized and effective healthcare strategies.

For instance, in March 2022, Wipro Limited (India) partnered with Pandorum (India). This partner...

The Market Access Solutions market is experiencing robust growth, driven by increasing complexities in healthcare regulations, the rising cost of pharmaceuticals and medical devices, and the growing need for efficient product launches. The market, currently estimated at $15 billion in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of 7% from 2025 to 2033. This growth is fueled by several key factors. Pharmaceutical and medical device companies are increasingly outsourcing market access functions to specialized firms, leveraging their expertise in pricing, reimbursement, regulatory affairs, and data analytics. The expanding use of data-driven insights and advanced analytics allows for more effective market access strategies. Furthermore, the increasing prevalence of chronic diseases and the development of innovative therapies further contribute to the market's expansion. The demand for sophisticated data analysis and integration capabilities is particularly high, as companies strive to optimize their market access strategies using real-world evidence and patient-level data. Segment-wise, the Data Analysis and Integration segment holds the largest share, reflecting the crucial role of data-driven decision-making in market access. The pharmaceutical company application segment dominates in terms of revenue contribution due to the intricate regulatory environment and reimbursement challenges inherent in the pharmaceutical industry. Geographic distribution shows a strong concentration in North America and Europe, driven by the presence of major pharmaceutical and medical device companies, established regulatory frameworks, and relatively higher healthcare spending. However, emerging markets in Asia Pacific are expected to witness significant growth during the forecast period, presenting lucrative opportunities for market players. Key players like IQVIA, ZS, and Syneos Health are leveraging their robust technology platforms and extensive expertise to secure a significant market share. The competitive landscape is characterized by both large multinational firms and niche players offering specialized services, leading to a dynamic and evolving market.

The rare disease clinical trials market size is projected to be valued at US$ 12,566.14 million in 2023 and is expected to rise to US$ 31,715.25 million by 2033. The sales of rare disease clinical trials are expected to record a significant CAGR of 9.7% during the forecast period.

Scope of the Report

In 2023, the leading contract research organizations worldwide included Laboratory Corporation of America Holdings, Thermo Fisher Scientific, and IQVIA. The first ranked company, Thermo Fisher Scientific, which acquired Pharmaceutical Product Development (PPD) in 2021, generated over 23 billion U.S. dollars in revenue through its clinical research business. Contract research organizations Contract research organizations (CROs) are companies that are contracted by larger pharmaceutical companies to manage select aspects of clinical trials. Today, CROs are essential for pharmaceutical research and development. Pharmaceutical companies are spending more money than ever on research and development, and there is no indication that spending will decrease in the future. Evidence suggests that CROs will become even more valuable. The clinical CRO market is expected to increase to over 100 billion U.S. dollars by the beginning of the next decade. Pharmaceutical research and development Globally, Roche and Johnson & Johnson will be the top pharmaceutical companies based on their projected research and development spending. There are regional differences in research and development among pharmaceutical companies. Of all pharmaceutical companies globally, those based in the U.S. develop the highest number of new chemical or biological entities.

Spread of NCEs between country income classes.

[250 Pages Report] Newly-released Healthcare Analytics Market analysis report by Future Market Insights shows that global sales of the Healthcare Analytics Market in 2021 were held at US$ 29.1 Billion. With 29.2%, the projected market growth from 2022 to 2032 is expected to be significantly higher than the historical growth. Software is expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 33% from 2022 to 2032.

Healthcare Analytics Market Report Scope

Market Overview The global decentralized clinical trial (DCT) platform market is rapidly expanding, driven by the need for efficient, cost-effective, and patient-centric clinical research. The market size is projected to reach USD XX million by 2033, growing at a CAGR of XX% during the forecast period (2023-2033). Key drivers include the increasing complexity of clinical trials, the growing adoption of telemedicine, and the need for faster and more flexible data collection. Market Trends and Segmentation The market is segmented into type (cloud-based and web-based) and company. Leading companies in the market include Medidata, IQVIA, Veeva Systems, and Castor. The market is also segmented by region, with North America dominating in terms of revenue share. Emerging trends in the market include the adoption of artificial intelligence (AI) and blockchain technology, the development of personalized medicine, and the increasing use of decentralized trial sites.